Topics
Glioblastoma | Treatment | Off-label Medications | Anti-alcohol drugs
Home > Publications > Topics > Glioblastoma > Treatment > Off-label Medications > Anti-alcohol drugs
Huang
J, Campian JL, DeWees TA, Skrott Z, Mistrik M, Johanns TM, Ansstas
G, Butt O, Leuthardt E, Dunn GP, Zipfel GJ, Osbun JW, Abraham C,
Badiyan S, Schwetye K, Cairncross JG, Rubin JB, Kim AH, Chheda MG.
A
phase 1/2 study of disulfiram and copper with concurrent radiation
therapy and temozolomide for patients with newly diagnosed
glioblastoma.
Int
J Radiat Oncol Biol Phys.
2024 May 19:S0360-3016(24)00660-6. doi:
10.1016/j.ijrobp.2024.05.009. PMID:
38768767. Interventional study˰ ˍ